Aethlon Medical Stock Forecast

AEMD's stock price has decreased by -63.07% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 2 analysts that cover Aethlon Medical stock have a consensus rating of "Buy" and an average price target of $28.75, which forecasts a 2246.94% increase in the stock price over the next year. The lowest target is $1.5 and the highest is $56.

Price Target: $28.75 (+2246.94%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$1.50	$28.75	$56	$56
Change	+22.45%	+2246.9%	+4471.4%	+4471.4%

Analyst Ratings

The average analyst rating for Aethlon Medical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Feb '25	Mar '25	Apr '25	May '25	Jun '25	Jul '25
Strong Buy	1	1	1	1	1	1
Buy	0	0	0	0	0	0
Hold	0	0	0	0	0	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	1	1	1	1	1	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Swayampakula Ramakanth HC Wainwright & Co.	HC Wainwright & Co.	Hold Initiates $1.5	Hold	Initiates	$1.5	+22.45%	Jul 7, 2025
Vernon Bernardino HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $56	Strong Buy	Reiterates	$56	+4,471.43%	Mar 10, 2025
Vernon Bernardino HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $56	Strong Buy	Reiterates	$56	+4,471.43%	Feb 19, 2025
Vernon Bernardino HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $56	Strong Buy	Reiterates	$56	+4,471.43%	Jan 30, 2025
Vernon Bernardino HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $56	Strong Buy	Reiterates	$56	+4,471.43%	Nov 15, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

-2.65

from -8.58

EPS Next Year

-0.64

from -2.65

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Mar 31, 2021	Mar 31, 2022	Mar 31, 2023	Mar 31, 2024	Mar 31, 2025	Mar 31, 2026	Mar 31, 2027
Revenue	659.10K	294.17K	574.25K	-	-	-	-
Revenue Growth	1.37%	-55.37%	95.21%	-	-	-	-
EPS	-52.18	-56.47	-46.86	-38.87	-8.58	-2.65	-0.64
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	5	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	n/a	n/a
Avg	n/a	n/a
Low	n/a	n/a

Revenue Growth

Revenue Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2026	2027
High	-1.75	-0.66
Avg	-2.65	-0.64
Low	-3.46	-0.62

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.